The goal posts will be moved again and we’ll get told that DCVax Direct will be used in a Phase 1 COVID-19 vaccine trial that is pending partnership and is somehow a (low) priority study for the NHS in the U.K. and has a Swiss Approval.
Again, where’s the “pump”? Hoping for an “interesting” ASM is not a claim by the company. I’m very well aware of the endpoints and generalized commentary as to the anticipated end of the trial. While you and others may be frustrated by past vague timelines (until the recent, more specific timeline), none of what you have referred to can reasonably be viewed as “pumping.”
Spot on - I can’t believe that a listed company can behave the Way they have , year in year out , lie after lie , broken promise after broken promise
And to those they do their Chinese whisper sawstone / multiple PR’s bidding Shame on you for abusing the trust of the many small retail punters that read your posts When if you were honest you know they’ve never told you a thing worth reporting